Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In patients with MASH and F1-F3 stage fibrosis treated with survodutide for 48 weeks across doses ranging from 2.4 to 6.0 mg, regression of MASH without fibrosis progression did not show a dose-dependent trend, with the best response observed at 4.8 mg (62% vs
Melanotic neuroectodermal tumour of infancy presenting as an undifferentiated round cell tumour in the soft tissue of the forearm
H.HarikrishnanR.et al
- Ung trc n 30 pht hoc sau n 1 gi
: : 990 : 50 100 2 1 -
2004 Dec William P
)
US$ 28.10
US$ 20.83
US$ 25.93
US$ 22.54
US$ 28.44
US$ 27.58
US$ 28.67
US$ 20.00
US$ 28.48
US$ 25.74
US$ 28.76
